Qingyi Wei, PhD

Professor in Population Health Sciences
Professor in Medicine
Member of the Duke Cancer Institute
Campus mail 103858, GSRB1 Room 3015C, Durham, NC 27710
Phone (919) 660-0562
Email address qingyi.wei@duke.edu

Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.

Area of Expertise: Epidemiology

Education and Training

  • Ph.D., Johns Hopkins Bloomberg School of Public Health, 1993
  • B.M., Nanjing Medical University (China), 1983

Publications

Wen, Juyi, Hongliang Liu, Lili Wang, Xiaomeng Wang, Ning Gu, Zhensheng Liu, Ting Xu, et al. “Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy..” J Thorac Oncol 13, no. 5 (May 2018): 660–75. https://doi.org/10.1016/j.jtho.2018.01.028.

PMID
29454863
Full Text

Tao, Ye, Erich M. Sturgis, Zhigang Huang, Ying Wang, Peng Wei, Jennifer Rui Wang, Qingyi Wei, and Guojun Li. “TGFβ1 Genetic Variants Predict Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy..” Clin Cancer Res 24, no. 9 (May 1, 2018): 2225–33. https://doi.org/10.1158/1078-0432.CCR-17-1904.

PMID
29463556
Full Text

Dai, W., H. Liu, X. Xu, C. Li, Z. Liu, and Q. Wei. “Genetic variants in the autophagy pathway genes predict melanoma survival.” In Journal of Investigative Dermatology, 138:S32–S32. ELSEVIER SCIENCE INC, 2018.

Scholars@Duke

Xu, X., H. Liu, W. Dai, K. Chen, C. Li, Z. Liu, and Q. Wei. “Genetic variants of the ketone metabolism gene PDSS1 predict melanoma survival.” In Journal of Investigative Dermatology, 138:S32–S32. ELSEVIER SCIENCE INC, 2018.

Scholars@Duke

Duan, Bensong, Jiangfeng Hu, Hongliang Liu, Yanru Wang, Hongyu Li, Shun Liu, Jichun Xie, et al. “Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk..” Int J Cancer 142, no. 7 (April 1, 2018): 1322–31. https://doi.org/10.1002/ijc.31171.

PMID
29168174
Full Text

Zhang, Ruoxin, Ming Jia, Yuan Xu, Danwen Qian, Mengyun Wang, Meiling Zhu, Menghong Sun, Jianhua Chang, and Qingyi Wei. “An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy..” Int J Cancer 142, no. 6 (March 15, 2018): 1218–29. https://doi.org/10.1002/ijc.31153.

PMID
29134637
Full Text

Lu, Zhongming, Erich M. Sturgis, Lijun Zhu, Hua Zhang, Ye Tao, Peng Wei, Qingyi Wei, and Guojun Li. “Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx..” Mol Carcinog 57, no. 3 (March 2018): 361–69. https://doi.org/10.1002/mc.22760.

PMID
29073727
Full Text

Feng, Yun, Yanru Wang, Hongliang Liu, Zhensheng Liu, Coleman Mills, Kouros Owzar, Jichun Xie, et al. “Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer..” Mol Carcinog 57, no. 2 (February 2018): 216–24. https://doi.org/10.1002/mc.22748.

PMID
29071797
Full Text

Xu, Yinghui, Yanru Wang, Hongliang Liu, Qiong Shi, Dakai Zhu, Christopher I. Amos, Shenying Fang, et al. “Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival..” Mol Carcinog 57, no. 1 (January 2018): 22–31. https://doi.org/10.1002/mc.22716.

PMID
28796414
Full Text

Shi, Tingyan, Pan Wang, Wenbin Tang, Rong Jiang, Sheng Yin, Di Shi, Qing Wang, Qingyi Wei, and Rongyu Zang. “Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer..” Cell Physiol Biochem 47, no. 5 (2018): 2088–96. https://doi.org/10.1159/000491477.

PMID
29975922
Full Text

Pages